title: [Lanzoptol efficacy at gastroesophageal reflux disease: results of multicenter study leader].
authors.forename: L B
authors.initials: LB
authors.lastname: Lazebnik
authors.forename: D S
authors.initials: DS
authors.lastname: Bordin
authors.forename: A A
authors.initials: AA
authors.lastname: Masharova
authors.forename: E S
authors.initials: ES
authors.lastname: V'iuchnova
authors.forename: N V
authors.initials: NV
authors.lastname: Zakharova
authors.forename: R A
authors.initials: RA
authors.lastname: Abdulkhakov
authors.forename: L V
authors.initials: LV
authors.lastname: Prokhorova
authors.forename: N N
authors.initials: NN
authors.lastname: Nikolaeva
mesh_terms: D053799:2-Pyridinylmethylsulfinylbenzimidazoles / Q000008:administration & dosage* / Q000009:adverse effects; D000328:Adult; D016145:Endoscopy, Digestive System; D004791:Enzyme Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D005764:Gastroesophageal Reflux / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D006863:Hydrogen-Ion Concentration; D064747:Lansoprazole; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D013997:Time Factors
chemical_list: D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D004791:Enzyme Inhibitors; D064747:Lansoprazole